NRC HEALTH NRC

About NRC HEALTH (NRC): stock profile, AI score and financials

NRC HEALTH (NRC) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores NRC at 41.3/100 on a composite quality score built from its SEC filings, placing it at rank #2,053 of 2,925 stocks — the bottom half of the AI-ranked universe. NRC scores in the top quartile across earnings quality (97.6). Areas of concern include revenue growth (18.9) and revenue scale (20.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 35.7/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), NRC HEALTH reports quarterly revenue of $35.4M, net income of $-3.3M, an operating margin of -9.2%. Top institutional holders of NRC by reported 13-F value include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT, BlackRock, MORGAN STANLEY, based on the most recent SEC filings. NRC trades on the Nasdaq exchange and files with the SEC under CIK 70487. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NRC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NRC HEALTH directly from SEC EDGAR.

Financials through the period ended Jun 30, 2026SEC EDGAR: CIK 70487 →